Objective: To investigate the associations between the Patient Global Assessment (PGA) and measures of disease activity in patients with rheumatoid arthritis (RA) in relation to disease duration and autoantibody status. Methods: 1412 patients from three independent cohorts were studied: a prospective cohort of 810 patients with early RA followed up for 24 months; a cross-sectional cohort of 210 patients with established RA in low disease activity; a cross-sectional cohort of 401 patients with established RA in moderate-to-high disease activity. Correlations of the PGA were analysed by Pearson's coefficients and multivariable linear regression at baseline and at months 6, 12 and 24 in the overall populations and after stratification for a...
To evaluate and compare the utility of commonly used outcome measures for assessing disease exacerba...
Current treatment strategies for rheumatoid arthritis (RA) aim to suppress the patient’s disease act...
ObjectivePatients and physicians commonly differ in their assessments of rheumatoid arthritis (RA) a...
Objectives: ACR/EULAR Boolean remission in RA is frequently not obtained solely due to a patient glo...
Patient-reported outcomes (PROs) reflect the patient's perspective and are used in rheumatoid arthri...
Objective: In current management paradigms of rheumatoid arthritis (RA), patient global assessment (...
Objective To assess the determinants of patients' (PTGL) and physicians' (MDGL) global assessment of...
International audienceThe ACR/EULAR Boolean remission criteria for rheumatoid arthritis (RA) include...
Background. In rheumatoid arthritis (RA), global disease activity is commonly evaluated, from the pa...
OBJECTIVES: There is an on-going debate about excluding patient global assessment (PGA) from composi...
Objective To test the longitudinal association between patient-reported outcome, Routine Assessment ...
OBJECTIVES: To assess (A) determinants of patient's global assessment of disease activity (PTGL) and...
BackgroundEstablished assessment tools for patients with rheumatoid arthritis (RA), including diseas...
OBJECTIVE: There is an ongoing debate about excluding patient's global assessment (PtGA) from compos...
In early undifferentiated arthritis (EUA), the relationship between inflammatory biomarkers and disa...
To evaluate and compare the utility of commonly used outcome measures for assessing disease exacerba...
Current treatment strategies for rheumatoid arthritis (RA) aim to suppress the patient’s disease act...
ObjectivePatients and physicians commonly differ in their assessments of rheumatoid arthritis (RA) a...
Objectives: ACR/EULAR Boolean remission in RA is frequently not obtained solely due to a patient glo...
Patient-reported outcomes (PROs) reflect the patient's perspective and are used in rheumatoid arthri...
Objective: In current management paradigms of rheumatoid arthritis (RA), patient global assessment (...
Objective To assess the determinants of patients' (PTGL) and physicians' (MDGL) global assessment of...
International audienceThe ACR/EULAR Boolean remission criteria for rheumatoid arthritis (RA) include...
Background. In rheumatoid arthritis (RA), global disease activity is commonly evaluated, from the pa...
OBJECTIVES: There is an on-going debate about excluding patient global assessment (PGA) from composi...
Objective To test the longitudinal association between patient-reported outcome, Routine Assessment ...
OBJECTIVES: To assess (A) determinants of patient's global assessment of disease activity (PTGL) and...
BackgroundEstablished assessment tools for patients with rheumatoid arthritis (RA), including diseas...
OBJECTIVE: There is an ongoing debate about excluding patient's global assessment (PtGA) from compos...
In early undifferentiated arthritis (EUA), the relationship between inflammatory biomarkers and disa...
To evaluate and compare the utility of commonly used outcome measures for assessing disease exacerba...
Current treatment strategies for rheumatoid arthritis (RA) aim to suppress the patient’s disease act...
ObjectivePatients and physicians commonly differ in their assessments of rheumatoid arthritis (RA) a...